Skip to main content

Table 1 Clinical characteristics of control subjects and RA patients

From: Unexpected arterial wall and cellular inflammation in patients with rheumatoid arthritis in remission using biological therapy: a cross-sectional study

 

Control (n = 17)

RA (n = 23)

p value

RA, DMARD (n = 10)

RA, anti-TNF (n = 13)

p value

Sex, male/female

7/10

8/15

0.680

3/7

5/8

0.637

Age, years

58 ± 13

58 ± 9

0.894

55 ± 11

60 ± 8

0.193

Body mass index, kg/m2

22 ± 2

26 ± 6

0.005

25 ± 6

26 ± 4

0.368

Smoking, yes/no

0/17

8/23

0.022

3/7

4/13

0.708

SBP, mmHg

127 ± 13

143 ± 23

0.014

131 ± 22

151 ± 20

0.028

DPB, mmHg

78 ± 8

87 ± 15

0.036

83 ± 15

90 ± 14

0.270

Total cholesterol, mmol/L

5.4 ± 0.9

5.4 ± 0.9

1.000

5.3 ± 0.9

5.4 ± 0.9

0.613

LDL cholesterol, mmol/L

3.3 ± 0.9

3.6 ± 1.1

0.396

3.4 ± 0.8

3.7 ± 1.3

0.284

HDL cholesterol, mmol/L

1.7 ± 0.4

1.5 ± 0.5

0.135

1.6 ± 0.5

1.4 ± 0.4

0.152

Triglycerides, mmol/L

0.66[0.5–1.0]

1.2[0.9–1.8]

0.001

1.1[0.9–1.4]

1.3[0.9–2.1]

0.393

CRP, mg/L

13[7–16]

18[13–30]

0.022

16[12–48]

19[14–30]

0.888

  1. Values are n (%), mean ± SD or median [IQR,] for skewed data
  2. RA rheumatoid arthritis, DMARD disease-modifying antirheumatic drug, TNF tumor necrosis factor, SBP systolic blood pressure, DBP diastolic blood pressure, LDL low-density lipoprotein, HDL high-density lipoprotein, CRP C-reactive protein